Correction: A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis
Main Authors: | I. B. Chaudhry, M. O. Husain, A. B. Khoso, M. I. Husain, M. H. Buch, T. Kiran, B. Fu, P. Bassett, I. Qurashi, R. ur Rahman, S. Baig, A. Kazmi, F. Corsi-Zuelli, P. M. Haddad, B. Deakin, N. Husain |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-021-01449-w |
Similar Items
-
Pilot randomised controlled trial of culturally adapted cognitive behavior therapy for psychosis (CaCBTp) in Pakistan
by: Muhammed Omair Husain, et al.
Published: (2017-12-01) -
A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol
by: Inti Qurashi, et al.
Published: (2017-11-01) -
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
by: Husain MI, et al.
Published: (2016-12-01) -
Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
by: Adam UU, et al.
Published: (2014-10-01) -
A Group Parenting Intervention for Depressed Fathers (LTP + Dads): A Feasibility Study from Pakistan
by: Muhammad I. Husain, et al.
Published: (2021-01-01)